Quit4TB Trial
This project is based at ARK in Bangladesh & TI in Pakistan.
Overview
Project title: Quit 4 TB Trial in Bangladesh and Pakistan
Programme: Preventable Risk Factors
Based at: ARK Foundation in Bangladesh & The Initiative in Pakistan
Start date: September/October 2022
End date:
Principal Investigators (PIs): Kamran Siddiqi, Amina Khan & Rumana Huque
Project team: Samina Huque, Asiful Haidar Chowdhury, Fahmidur Rahman, Shakhawat Hossain Rana, Mahmoud Danaee, Ai Keow Lim, John Norrie, Steve Parrott, Linda Bauld, Genevie Fernandes, Melanie Böckmann
Background
Tuberculosis (TB) and tobacco smoking are co-epidemics that disproportionately affect many low and middle-income countries (LMICs). People who smoke are more likely to become infected with TB, be more infectious and develop worse health outcomes compared to their non-smoker counterparts.
RESPIRE researchers, in collaboration with the World Health Organization, had previously developed a mobile Health programme known as mTB-Tobacco. The programme is designed to support people recovering from TB who also wish to stop smoking by sending carefully crafted and timed SMS messages to their mobile devices as they undergo treatment for TB.
Aim and Impact
This project aims to assess the effectiveness and cost effectiveness of mTB-Tobacco in Bangladesh and Pakistan – two countries with a high disease burden of TB and tobacco.
Milestones
- Project launched in Bangladesh on 5 September 2022
- Project launch in Pakistan on 28 October 2022
- Logos approved by PIs